Question follow-through · 19627

Cancer: Health Services

To ask the Secretary of State for Health and Social Care, what measurable improvements in (a) workforce capacity, (b) research activity, (c) clinical trial access, (d) speed of diagnosis and (e) patient outcomes are expected as a result of the work of the

answeredDepartment of Health and Social Care

About this written question

A written question asks a government minister for information in writing. Parliament publishes the question and any answer.

Answering body
Department of Health and Social Care
Tabled
16 Jul 2026
Target answer date
2 Sept 2026
Answer
7 Sept 2026 · 53 calendar days after tabling

Elapsed calendar days describe the record timeline, not whether Parliament considers an answer on time.

Votes on this topic

These Commons divisions share a topic label. The question did not necessarily lead to a vote.

Recorded timeline

  1. 16 Jul 2026

    Question tabled

    To ask the Secretary of State for Health and Social Care, what measurable improvements in (a) workforce capacity, (b) research activity, (c) clinical trial access, (d) speed of diagnosis and (e) patient outcomes are expected as a result of the work of the

  2. 2 Sept 2026

    Target answer date

    Date supplied by the official written-questions record.

  3. 7 Sept 2026

    Answer published

    The National Cancer Plan, published on 4 February 2026, sets out the Government's long-term approach to improving outcomes for all cancer patients, including those affected by rare cancers such as brain tumours. As part of the plan, the Government committ...

Open official record

Official data retrieved 28 Sept 2026.

Later records

Possible follow-up questions

Strong links require the same MP, department and exact heading. Other same-department questions are shown as unreviewed candidates, not as confirmed follow-ups. No debate link is asserted unless a stable source relationship exists.

No later same-department questions indexed.

This is an absence in covered public data, not evidence that no follow-up occurred elsewhere.